Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation

International Journal of Colorectal Disease

Volumn 18, Issue 4, 2003, Pages 309-313

  Hertervig, Erik ^a   Nilsson, Åke ^a   Nilbert, Mef ^a   Duan, Rui Dong ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenomatous polyposis coli; Alkaline sphinggomyelinase; Colorectal

Indexed keywords

APC PROTEIN; BETA CATENIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ACIDITY; ADULT; AGED; ALKALINITY; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLON; COLON POLYPOSIS; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; SMALL INTESTINE;

EID: 0038150578     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-002-0471-y     Document Type: Article

References (31)

1. Kolesnick RN (1991) Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30:1-38
2. Hannun YA, Linardic CM (1993) Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim Biophys Acta 1154:223-236
3. Spence MW (1993) Sphingomyelinases. Adv Lipid Res 26:3-23
4. Chatterjee S (1993) Neutral sphingomyelinase. Adv Lipid Res 26:25-48
5. Nilsson Å (1969) The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 176:339-347
6. Duan R-D, Nyberg L, Nilsson Å (1995) Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characterization. Biochim Biophys Acta 1259:49-55
7. Duan R-D, Hertervig E, Nyberg L, Hauge T, Sternby B, Lillienau J, Farooqi A, Nilsson Å (1996) Distribution of alkaline sphingomyelinase activity in human beings and animals. Dig Dis Sci 41:1801-1806
8. Nyberg L, Nilsson Å, Lundgren P, Duan R-D (1997) Localization and capacity of sphingolyelin digestion in the rat intestinal tract. J Nutr Biochem 8:112-118
9. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769-1771
10. Dillehay DL, Webb SK, Schmelz E-M, Merrill AH (1994) Dietary sphingomyelin inhibits 1:2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124:615-620
11. Schmelz EM, Dillehay DL, Webb SK, Reiter A, Adams L Merrill AH Jr (1996) Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1:2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56:4936-4941
12. Hertervig E, Nilsson A, Nyberg L, Duan RD (1997) Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 79:448-453
13. Hertervig E, Nilsson Å, Björk J, Hultkrantz R, Duan R-D (1999) Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity; a key factor to the unrestrained cell proliferation. Br J Cancer 81:232-236
14. Kinzler KW, Nilbert MC, Su L-K, Vogelstein R, Bryan TM, Levy DB, Smith KJ, Preisinger C, Hedge P, McKechnie D, et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661-664
15. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
16. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 259:235-237
17. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170
18. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670
19. Duan RD, Nilsson Å (1999) Enzymes hydrolysing sphingolipids in gastrointestinal tract. Methods Enzymol 311:276-286
20. Gatt S (1976) Magnesium-dependent sphingomyelinase. Biochem Biophys Res Commun 68:235-241
21. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW (1993) Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982-1987
22. Levi E, Stryker SJ, Rao MS (1996) p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event? Am J Gastroenterol 91:11-14
23. Shivapurkar N, Huang L, Ruggeri B, Swalsky PA, Bakker A, Finkelstein S, Frost A, Silverberg S (1997) K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett 115:39-46
24. Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B, Kinzler KW (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523-5526
25. Kashiwagi H, Spigelman AD, Talbot IC, Debinski HS, McKie AB, Lemoine NR, Phillips RK (1997) p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br J Surg 84:826-829
26. Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MT, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S (1996) MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 56:2922-2926
27. Giardiello FM, Hamilton SR, Krush AJ Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316
28. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560
29. Chan TA, Morin PJ, Vogelstein B, Kinzler KW (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95:681-686
30. Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, Bhattacharyya AK, Roy H, Khare S, Brasitus TA (1994) Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 54:5071-5074
31. Cheng Y, Tauschel H-T, Nilsson Å, Duan R-D (1999) Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colon. Scand J Gastroenterol 34:915-920